Emeren Group Ltd Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited condensed consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q2 FY2024 As of Jun 30, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable trade, net
Notes receivable
Inventories
Accounts receivable unbilled, net
Advances to suppliers
Amounts due from related parties
Value added tax recoverables
Income tax recoverable
Project assets, current
Prepaid expenses and other current assets, net
Deferred convertible notes issuance costs-current
Assets held-for-sale
Deferred project costs
Assets held for sale
Derivative assets
Deferred tax assets-current, net
Contract costs
Total current assets

Property, plant and equipment, net
Prepaid land use right, net
Deferred convertible notes issuance costs-non-current
Advances for purchases of property, plant and equipment, net
Advances to suppliers-non-current, net
Deferred tax assets, net
Project assets, non-current
Deferred project costs non-current
Operating lease, right-of-use assets
Finance lease, right-of-use assets
Investment in U.S. treasury notes+
Investment in U.S. treasury notes
Other non-current assets
Assets of discontinued operations non-current
Goodwill
Total assets

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Convertible bond payable, net
Accounts payable
Advances from customers-current
Advances from customers
Short-term borrowings
Bond payable
Amounts due to related parties
Long-term borrowings, current
Income tax payable
Deferred tax liabilities
Derivative liabilities
Warrant liability
Salaries payable
Deferred project revenue
Operating lease liabilities, current
Failed sales-leaseback and finance lease liabilities, current
Other current liabilities
Related party
Nonrelated party
Total other current liabilities
Liabilities held for sale
Total current liabilities

Convertible notes payable-non-current
Advances from customers-non-current
Warranty
Deferred project revenue non-current
Deferred subsidies
Other long-term liabilities
Failed sale-lease back and capital lease liabilities
Liabilities of discontinued operations non-current
Long-term borrowings, non-current
Operating lease liabilities, non-current
Failed sales-leaseback and finance lease liabilities, non-current
Deferred tax liabilities
Total liabilities
Shareholders' equity
Common shares (1,000,000,000 shares, no par value, authorized at September 30, 2025 and December 31, 2024; 637,920,142 shares issued and 513,216,222 shares outstanding at September 30, 2025; 652,821,742 shares issued and 513,216,222 shares outstanding at December 31, 2024)
Additional paid-in capital
Treasury stock, at cost (124,703,920 and 124,703,920 shares as of September 30, 2025 and December 31, 2024, respectively)
Accumulated deficit
Accumulated other comprehensive loss
Emeren Group Ltd shareholders' equity
Non-controlling interest
Total shareholders' equity
Total liabilities and shareholders' equity

Comments